Company Introduction

Nanjing Letop Biotechnology Co., Ltd. is a scientific and technological innovative enterprise integrating research and development, production and sales of functional raw materials. The company has a biological fermentation platform and the core technology of enzyme catalysis. Relying on the strong research and development and technical background of Sino-US pharmaceutical companies, the company focuses on providing consumers with high-quality and clinically valuable raw materials with functional value with the pharmaceutical concept.

At present, the company sells more than 20 products, including:
Functional food raw materials: small molecule chondroitin sulfate LetopCS, drilonetin, GABA, cartilage extract, NMN, ergothioneine, etc.;
Medical beauty raw materials: nano-sodium hyaluronate nmHA and customized molecular weight sodium hyaluronate, acetylated sodium hyaluronate, cationic sodium hyaluronate, PDRN, ergothionein, ecdoine, recombinant Type III humanized collagen, GABA, etc.;
Pharmaceutical intermediates and apis: Degu insulin side chain, progesterone, retinoic acid, Vitamin K1, etc.

In order to expand the production scale and market investment of the enterprise, the two new production bases of "Letop-Lianyungang Chengong Pharmaceutical Co., LTD." and "Letop-Nanjing Mingyang Biotechnology Co., LTD." will be built and put into use soon.

"Letop - Lianyungang Chengong Pharmaceutical Co., LTD.", a base project a total investment of 500 million yuan, covers an area of 35,000-square-meter of land, with an annual output of hormone biological raw materials (5 tons), biological fermentation raw materials (200 kg) and supporting preparations (1 billion hormone tablets, capsules, content tablets/capsules). The output value reached no less than 200 million yuan after all.

"Letop-Nanjing Mingyang Biotechnology Co., LTD." (operating under the Letop brand) is another base project with a total investment of 250 million yuan.